Cholinergic neurotransmitter system

The cholinergic neurotransmitter system is a fundamental signaling network that employs acetylcholine (ACh) to transmit signals across junctions in the central and peripheral nervous systems (StatPearls: Physiology, Acetylcholine). In the brain, it is essential for cognitive processes including memory, arousal, and attention, while in the periphery, it governs voluntary muscle movement and parasympathetic autonomic activity (NCBI: The Cholinergic System). The system's architecture includes biosynthetic enzymes like choline acetyltransferase (ChAT), degradative enzymes such as acetylcholinesterase (AChE), and two distinct receptor classes: ionotropic nicotinic receptors and metabotropic muscarinic receptors (UniProt: Acetylcholinesterase). Pathological decline in cholinergic tone is a hallmark of Alzheimer's disease, whereas overactivity or receptor blockade can lead to toxic syndromes (PubChem: Acetylcholine). Therapeutic strategies often focus on enhancing ACh levels via cholinesterase inhibitors or using specific agonists and antagonists to manage conditions like glaucoma, myasthenia gravis, and overactive bladder (NIH: Myasthenia Gravis). Additionally, the system is a target for various toxins and insecticides that disrupt the balance of acetylcholine, leading to severe neuromuscular and autonomic dysfunction (StatPearls: Physiology, Acetylcholine). Modern drug development continues to explore subtype-specific muscarinic and nicotinic modulators to minimize side effects while treating complex neuropsychiatric disorders (NCBI: The Cholinergic System).

Other names

Cholinergic system (NCBI: The Cholinergic System)Acetylcholine signaling systemACh system

Inhibition of acetylcholinesterase, activation or blockade of muscarinic and nicotinic acetylcholine receptors, and modulation of acetylcholine release or reuptake (StatPearls: Physiology, Acetylcholine).